DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Robin Respaut - 2 Brian Thevenot - 2 Sergio Perez - 1 Teresa Ribera - 1 Bernard Respaut - 1 Mats Gustavsson - 1 Boliden - 1 Gustavsson - 1
Top related locs:
U.S Europe Alcobendas Madrid Spain Ukraine San EU
Top related orgs:
REUTERS - 3 Thomson - 3 FDA - 2 Union - 1 Spain's Energy - 1 Producers - 1 European Copper Institute - 1 EU - 1

Search resuls for: "Respaut"


4 mentions found


☆ New EU power market, same old problems for metals sector
  + stars: | 2023-11-07 | by ( Andy Home | Thomson Reuters | Senior Metals Columnist Who Previously Covered Industrial Metals Markets For Metals Week | ) www.reuters.com   time to read: +6 min
REUTERS/Sergio Perez Acquire Licensing RightsLONDON, Nov 7 (Reuters) - European Union (EU) energy ministers last month struck a deal to reform the bloc's power market. German power market forwards for 2024 and 2025LIGHT-TOUCH REFORMEuropean power prices have fallen a long way from their 2022 peaks, when the region was still reeling from the reduction in Russian gas supplies. EU member states were deeply split on proposals for more fundamental reform of Europe's power market to allow for a complete break of the gas-power price linkage. The hard-won compromise keeps the existing market mechanism, which its supporters claim is more efficient than other models in a liberalised electricity market. The bloc's power prices have historically been twice those of the U.S., but are now three or four times higher.
Persons: Sergio Perez, Teresa Ribera, Bernard Respaut, Mats Gustavsson, Boliden, Gustavsson, Respaut, Jan Harvey Organizations: REUTERS, Union, Spain's Energy, Producers, European Copper Institute, EU, Alcoa, PPA, European Commission, Metals, Reuters, Thomson Locations: Alcobendas, Madrid, Spain, Ukraine, San, EU, U.S, Ireland, Europe
☆ Wegovy, other weight-loss drugs scrutinized over reports of suicidal thoughts
  + stars: | 2023-09-28 | by ( Robin Respaut Chad Terhune | Robin Respaut | Chad Terhune | ) www.reuters.com   time to read: +14 min
Accounts of suicidal thoughts linked to this class of drugs are drawing increasing scrutiny, including an investigation by European regulators announced in July. More than half of the narrative summaries describe suicidal thoughts appearing shortly after the person started the medicine or increased the dose. Wegovy’s U.S. prescribing label, produced with FDA approval, says suicidal thoughts or attempts have been reported in clinical trials for other weight-loss medicines. Sanofi's Acomplia, which never won U.S. approval, was withdrawn in Europe in 2008 after being linked to suicidal thoughts. She said she has not experienced any suicidal thoughts on that drug.
Persons: Dawn Heidlebaugh, Megan Jelinger, ”, Heidlebaugh, Eli Lilly, Thomas J, Moore, aren't, It’s, Novo, Dr, Erick Turner, Turner, Novo’s, drugmakers, Sanofi's, Sanofi, Contrave, John Amos, Lilly, Reuters weren’t, Lisa Wood, ” Wood, Sarah Sobol, you’re, Sobol, ’ ” Katherine, Jayson Chesnutt, Chesnutt, Robin Respaut, Chad Terhune, Maggie Fick, Ludwig Burger, Michele Gershberg, Brian Thevenot Organizations: REUTERS, Novo, U.S . Food, Drug Administration, Reuters, FDA, Johns Hopkins Bloomberg School of Public Health, Oregon Health & Science University, Novo Nordisk, U.S ., European Union, European Medicines Agency, U.S, Currax Pharmaceuticals, Vivus, Facebook, Thomson Locations: Findlay , Ohio, U.S, Ohio, Novo, Canada, Europe, Carolina, Buffalo , New York, North Carolina, Indiana
☆ Merck accused of downplaying early evidence of drug’s brain impact
  + stars: | 2023-06-26 | by ( Robin Respaut Dan Levine | Robin Respaut | Dan Levine | ) www.reuters.com   time to read: +4 min
[1/6] Jan Gilpin poses with a bottle of the asthma and allergy drug Singulair, first prescribed to her son when he was three-years-old, at her home in Newton, Massachusetts, U.S., June 21, 2023. That team found in 2015 that the drug’s distribution into the brain was more significant than its label described. Lawsuits filed against Merck cite this 1996 patent as evidence of Merck’s knowledge of the drug’s potential brain impacts. Marschallinger and her colleagues in Austria came away with a different finding when they reviewed Merck’s original research and did some of their own. Marschallinger said it would have been logical for the FDA to require Merck to investigate the brain impacts more thoroughly once reports of mental-health problems emerged.
Persons: Jan Gilpin, Singulair, Brian Snyder, Merck, Julia Marschallinger, Marschallinger, ” Marschallinger, “ It’s, Robin Respaut, Dan Levine, Janet Roberts, Brian Thevenot Organizations: REUTERS, Brian Snyder Companies Merck, Co, FDA, Molecular Regenerative, Singulair, Merck, Thomson Locations: Newton , Massachusetts, U.S, Austria
☆ England’s trans teens, lost in limbo, face mounting barriers to care
  + stars: | 2022-12-15 | by ( Jennifer Rigby | Robin Respaut | Chad Terhune | ) www.reuters.com   time to read: +35 min
The UK government has promised to overhaul the youth gender care system, after it was deemed inadequate by England’s regulator of health and social care. They described a deeply flawed system that is now hobbled by a toxic political climate around gender care. The letter said a decision would be made at some point from early 2022 on whether the child “is likely to meet the access criteria” for gender care. The family has received no NHS gender care or mental health support since the referral, she said. These recommended supporting “identity exploration” and mental health treatment as the first steps to ensure that any psychological issues are addressed.
0 next >>
Total: 4